Invasive Pneumococcal Disease
📧 Sign up to get email alerts when something new happens for Invasive Pneumococcal Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-05EMA Authorised: Prevenar 13 (Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 3;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6A;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19A;Pneumococcal polysaccharide serotype 19F;Pneumococcal polysaccharide serotype 23F) — Pfizer Europe MA EEIG
EMA authorised Prevenar 13, a 13-valent pneumococcal conjugate vaccine, for immunization against pneumococcal infections in the EU. The vacc…